Communiqués PURE Bioscience, Inc.

Actions

PURE

US74621T2096

Temps Différé OTC Markets Autres places de cotation 17:45:16 27/06/2024			Varia. 5j.	Varia. 1 janv.
0,0799 ^USD	+30,98%		+6,53%	-38,40%

06/05	PURE Bioscience nomme Darin Zehr au conseil d'administration	CI
18/03	PURE Bioscience, Inc. annonce ses résultats pour le deuxième trimestre et les six mois terminés le 31 janvier 2024	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

PURE Bioscience Announces an International Supply and License Agreement with AgroVet Alliance	18/06	BU
PURE Bioscience Reports Fiscal Third Quarter 2024 Financial Results	14/06	BU
PURE Bioscience Appoints Darin Zehr to Board of Directors	06/05	BU
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results	18/03	BU
PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results	14/12	BU
PURE Bioscience Reports Fiscal 2023 Financial Results	30/10/23	BU
PURE Bioscience to unveil “PURE Genius” Food Safety Program at the Annual International Association for Food Protection Meeting	05/07/23	BU
PURE Bioscience Reports Fiscal 2023 Third Quarter And Nine-Month Financial Results	14/06/23	BU
PURE BIOSCIENCE, INC. : Change in Directors or Principal Officers (form 8-K)	21/03/23	AQ
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results	20/03/23	AQ
PURE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	17/03/23	AQ
PURE BIOSCIENCE, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	17/03/23	AQ
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results	17/03/23	BU
PURE BIOSCIENCE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	10/02/23	AQ
PURE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/12/22	AQ
PURE BIOSCIENCE, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	14/12/22	AQ
PURE Bioscience Reports Fiscal First Quarter 2023 Financial Results	14/12/22	BU
PURE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	28/10/22	AQ
PURE BIOSCIENCE, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	28/10/22	AQ
PURE Bioscience Reports Fiscal 2022 Financial Results	28/10/22	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués PURE Bioscience, Inc.

Actions

PURE

US74621T2096

Communiqués

Filtres